glp 1 cost australia Who Shouldn't Be On GLP-1 Medications? & Sustainability Australia GLP-1 Receptor Agonist Market

John Wilding, Professor of Medicine at the University of Liverpool and co-author of the STEP 1 trial [9]

Thirdly , theres also a patent application (IN202047010224) (pdf) pending by Novo Nordisk, filed in 2020 with priority date of 24/08/2017, for a specific formulation of semaglutide (the active ingredient in its commercial blockbuster drug, Ozempic) described as Semaglutide liquid formulations (no more than 0.01% (w/w) phenol. Adding to the complexity is a recent revocation petition filed by DRL in May 2025 (as reported by the media here)

Chronic conditions involving ongoing tissue damage, such as tendinopathy, may also respond to the peptide enhanced repair signaling

From month two, you pay the standard price, and the cost rises again as the dose increases over the first few months

That process takes months and requires a sustained record of compliance